Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer
Clinical trial NCT05512780 · UNKNOWN
Trial details
- NCT number
- NCT05512780
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-10
- Primary completion
- 2023-08-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.